Analysis of mutations in DNA damage repair pathway gene in Chinese patients with hepatocellular carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analysis of mutations in DNA damage repair pathway gene in Chinese patients with hepatocellular carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-19
DOI
10.1038/s41598-022-16604-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants
- (2021) Milind Javle et al. JAMA Oncology
- Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial
- (2021) Johann S de Bono et al. LANCET ONCOLOGY
- Mapping genomic and epigenomic evolution in cancer ecosystems
- (2021) Toshikazu Ushijima et al. SCIENCE
- USP37 regulates DNA damage response through stabilizing and deubiquitinating BLM
- (2021) Chenming Wu et al. NUCLEIC ACIDS RESEARCH
- Advances in molecular classification and precision oncology in hepatocellular carcinoma
- (2020) Sandra Rebouissou et al. JOURNAL OF HEPATOLOGY
- Association between DNA damage repair gene somatic mutations and immune‐related gene expression in ovarian cancer
- (2020) Wenjuan Tian et al. Cancer Medicine
- Alterations in DNA damage repair genes in primary liver cancer
- (2019) Jianzhen Lin et al. CLINICAL CANCER RESEARCH
- DDR Alterations as a Surrogate Marker for TMB in SCLC — Use it or Lose it?
- (2019) Surein Arulananda et al. Journal of Thoracic Oncology
- Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers
- (2018) Min Yuen Teo et al. JOURNAL OF CLINICAL ONCOLOGY
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
- (2018) Andrew Tutt et al. NATURE MEDICINE
- High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods
- (2017) Dan Su et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response
- (2017) Yunhui Li et al. Nature Communications
- International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007
- (2016) Jessica L. Petrick et al. INTERNATIONAL JOURNAL OF CANCER
- Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic
- (2016) Aniello Cerrato et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma
- (2016) T-Y Na et al. ONCOGENE
- Comet assay to measure DNA repair: approach and applications
- (2014) Amaya Azqueta et al. Frontiers in Genetics
- Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: Possible implications on survival
- (2012) Seok Won Jung et al. JOURNAL OF HEPATOLOGY
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More